The Effects of Antidepressants and Quetiapine on Heart Rate Variability

W.-L. Huang; S.-C. Liao; T. B. J. Kuo; L.-R. Chang; T.-T. Chen; I.-M. Chen; C. C. H. Yang

doi:10.1055/s-0042-102964

Pharmacopsychiatry, Table of Contents

Pharmacopsychiatry 2016; 49(05): 191-198
DOI: 10.1055/s-0042-102964

Original Paper

The Effects of Antidepressants and Quetiapine on Heart Rate Variability

Authors

W.-L. Huang

¹Department of Psychiatry, National Taiwan University Hospital, Yun-Lin Branch, Yunlin, Taiwan

²Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan

³Department of Psychiatry, College of Medicine, National Taiwan University, Taipei, Taiwan

⁴Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
S.-C. Liao

²Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan

³Department of Psychiatry, College of Medicine, National Taiwan University, Taipei, Taiwan
T. B. J. Kuo

⁵Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan

⁷Institute of Translational and Interdisciplinary Medicine, National Central University, Taoyuan, Taiwan
L.-R. Chang

²Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan

³Department of Psychiatry, College of Medicine, National Taiwan University, Taipei, Taiwan
T.-T. Chen

¹Department of Psychiatry, National Taiwan University Hospital, Yun-Lin Branch, Yunlin, Taiwan
I.-M. Chen

²Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan

⁶Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei, Taiwan
C. C. H. Yang

⁵Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan

Abstract

Introduction: The autonomic effects of antidepressants and quetiapine on heart rate variability (HRV) are inconsistent based on past studies. The aim of this study was to explore their influence on the HRV of psychiatric patients without psychotic symptoms.

Methods: A total of 94 patients with depression, anxiety, or somatic symptoms, were recruited into this study. Based on their medication, 4 groups were identified: the no antidepressant group (n=19), the SSRI group (using sertraline or escitalopram, n=53), the other antidepressants group (using venlafaxine or mirtazapine, n=9), and the augmentation group (AG, using an antidepressant+quetiapine, n=13). The HRV of the 4 groups were compared. The correlations between HRV and the medication(s) used were clarified.

Results: Among the 4 groups, the AG had the lowest HRV with its total power (TP), very low frequency power (VLF) and low frequency power (LF) of HRV being significantly different from those of the other groups. Age and using quetiapine were found to be negatively correlated with TP, VLF and LF. With this study group, the autonomic effects of antidepressants were found not to be significant.

Discussion: Among psychiatric patients without psychotic symptoms, quetiapine causes an overt decrease in HRV.

Key words

heart rate variability - autonomic nervous system - antidepressants - quetiapine

Full Text

References

References
1 Servant D, Logier R, Mouster Y et al. Heart rate variability. Applications in psychiatry. L’Encephale 2009; 35: 423-428
2 Lo Turco G, Grimaldi Di Terresena L. Spectral analysis of Heart Rate Variability in psychiatric patients: autonomic nervous system evaluation in psychotic, anxiety and depressive disorders. Rivista di psichiatria 2012; 47: 139-148
3 Yeragani VK. Heart rate and blood pressure variability: implications for psychiatric research. Neuropsychobiology 1995; 32: 182-191
4 [Anonymous]. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996; 93: 1043-1065
5 Kuo TB, Lin T, Yang CC et al. Effect of aging on gender differences in neural control of heart rate. Am J Physiol 1999; 277: H2233-H2239
6 Huang WL, Chang LR, Kuo TB et al. Impact of antipsychotics and anticholinergics on autonomic modulation in patients with schizophrenia. J Clin Psychopharmacol 2013; 33: 170-177
7 Udupa K, Thirthalli J, Sathyaprabha TN et al. Differential actions of antidepressant treatments on cardiac autonomic alterations in depression: A prospective comparison. Asian J Psychiatr 2011; 4: 100-106
8 Licht CM, de Geus EJ, van Dyck R et al. Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biol Psychiatry 2010; 68: 861-868
9 Kemp AH, Quintana DS, Gray MA et al. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry 2010; 67: 1067-1074
10 Zimmermann-Viehoff F, Kuehl LK, Danker-Hopfe H et al. Antidepressants, autonomic function and mortality in patients with coronary heart disease: data from the Heart and Soul Study. Psychol Med 2014; 44: 2975-2984
11 Dinleyici EC, Kilic Z, Sahin S et al. Heart rate variability in children with tricyclic antidepressant intoxication. Cardiol Res Pract 2013; 2013: 196506
12 van Zyl LT, Hasegawa T, Nagata K. Effects of antidepressant treatment on heart rate variability in major depression: a quantitative review. Biopsychosoc Med 2008; 2: 12
13 Volkers AC, Tulen JH, van den Broek WW et al. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder. Pharmacopsychiatry 2004; 37: 18-25
14 Siepmann M, Krause S, Joraschky P et al. The effects of St John’s wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men. Br J Clin Pharmacol 2002; 54: 277-282
15 Evans DL, Staab J, Ward H et al. Depression in the medically ill: management considerations. Depress Anxiety 1996; 4: 199-208
16 Rechlin T, Claus D, Weis M et al. Decreased heart rate variability parameters in amitriptyline treated depressed patients: biological and clinical significance. Eur Psychiatry 1995; 10: 189-194
17 Srinivasan K, Ashok MV, Vaz M et al. Effect of imipramine on linear and nonlinear measures of heart rate variability in children. Pediatr Cardiol 2004; 25: 20-25
18 Yeragani VK, Rao KA, Pohl R et al. Heart rate and QT variability in children with anxiety disorders: a preliminary report. Depress Anxiety 2001; 13: 72-77
19 Tulen JH, Bruijn JA, de Man KJ et al. Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770). J Clin Psychopharmacol 1996; 16: 135-145
20 O’Regan C, Kenny RA, Cronin H et al. Antidepressants strongly influence the relationship between depression and heart rate variability: findings from The Irish Longitudinal Study on Ageing (TILDA). Psychol Med 2014; 1-14
21 Licht CM, de Geus EJ, van Dyck R et al. Association between anxiety disorders and heart rate variability in The Netherlands Study of Depress Anxiety (NESDA). Psychosom Med 2009; 71: 508-518
22 Licht CM, de Geus EJ, Seldenrijk A et al. Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 2009; 53: 631-638
23 Koschke M, Boettger MK, Schulz S et al. Autonomy of autonomic dysfunction in major depression. Psychosom Med 2009; 71: 852-860
24 Bar KJ, Greiner W, Jochum T et al. The influence of major depression and its treatment on heart rate variability and pupillary light reflex parameters. J Affect Disord 2004; 82: 245-252
25 Roose SP, Laghrissi-Thode F, Kennedy JS et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. Jama 1998; 279: 287-291
26 Rechlin T, Weis M, Claus D. Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic functions. Pharmacopsychiatry 1994; 27: 124-128
27 Blumenthal JA, Sherwood A, Babyak MA et al. Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol 2012; 60: 1053-1063
28 Shea AK, Kamath MV, Fleming A et al. The effect of depression on heart rate variability during pregnancy. A naturalistic study. Clin Auton Res 2008; 18: 203-212
29 Glassman AH, Bigger JT, Gaffney M et al. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement. Arch Gen Psychiatry 2007; 64: 1025-1031
30 Dai F, Lei Y, Chen JD. Inhibitory effects of desvenlafaxine on gastric slow waves, antral contractions, and gastric accommodation mediated via the sympathetic mechanism in dogs. Am J Physiol Gastrointest Liver Physiol 2011; 301: G707-G712
31 Terhardt J, Lederbogen F, Feuerhack A et al. Heart rate variability during antidepressant treatment with venlafaxine and mirtazapine. Clin Neuropharmacol 2013; 36: 198-202
32 Chang JS, Ha K, Yoon IY et al. Patterns of cardiorespiratory coordination in young women with recurrent major depressive disorder treated with escitalopram or venlafaxine. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39: 136-142
33 Agelink MW, Majewski T, Wurthmann C et al. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol 2001; 21: 8-13
34 Kim JH, Yi SH, Yoo CS et al. Heart rate dynamics and their relationship to psychotic symptom severity in clozapine-treated schizophrenic subjects. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 371-378
35 Mueck-Weymann M, Rechlin T, Ehrengut F et al. Effects of olanzapine and clozapine upon pulse rate variability. Depress Anxiety 2002; 16: 93-99
36 Eschweiler GW, Bartels M, Langle G et al. Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine?. Pharmacopsychiatry 2002; 35: 96-100
37 Malaspina D, Dalack G, Leitman D et al. Low heart rate variability is not caused by typical neuroleptics in schizophrenia patients. CNS Spectr 2002; 7: 53-57
38 Hempel RJ, Tulen JH, van Beveren NJ et al. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia. J Psychopharmacol 2009; 23: 697-707
39 Wang YC, Yang CC, Bai YM et al. Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up. Neuropsychobiology 2008; 57: 200-205
40 Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 258-266
41 Lee S, Creed FH, Ma YL et al. Somatic symptom burden and health anxiety in the population and their correlates. J Psychosom Res 2015; 78: 71-76
42 Lucock MP, Morley S. The health anxiety questionnaire. Brit J Health Psych 1996; 1: 137-150
43 Beck AT, Steer RA, Ball R et al. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996; 67: 588-597
44 Steer RA, Rissmiller DJ, Ranieri WF et al. Structure of the computer-assisted Beck Anxiety Inventory with psychiatric inpatients. J Pers Assess 1993; 60: 532-542
45 Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken) 2011; 63 (Suppl. 11) S467-S472
46 Taylor JA, Carr DL, Myers CW et al. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation 1998; 98: 547-555
47 Jain FA, Cook IA, Leuchter AF et al. Heart rate variability and treatment outcome in major depression: a pilot study. Int J Psychophysiol 2014; 93: 204-210
48 Kemp AH, Brunoni AR, Santos IS et al. Effects of depression, anxiety, comorbidity, and antidepressants on resting-state heart rate and its variability: an ELSA-Brasil cohort baseline study. Am J Psychiatry 2014; 171: 1328-1334
49 Agelink MW, Majewski TB, Andrich J et al. Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam. Crit Care Med 2002; 30: 997-1006
50 Unoki T, Grap MJ, Sessler CN et al. Autonomic nervous system function and depth of sedation in adults receiving mechanical ventilation. American journal of critical care: an official publication. Am J Crit Care 2009; 18: 42-50 quiz 51